Disclaimer: BPC-157 is not intended to diagnose, treat, cure, or prevent any medical condition
These graphs suggested that there may be, at least some degree of, clustering by treatment group
In contrast, AMYRs have high affinity and potency in response to amylin peptides, but weak response to human CT (hCT) 7,8
M., & Hetzer, M
Low vitamin B12 levels among newly-arrived refugees from Bhutan, Iran and Afghanistan: a multicentre Australian study
What the Research Says About Safety Clinical studies on AOD9604 indicate that the peptide is generally welltolerated: In human trials, no significant adverse effects were reported at doses up to 1 mg/day (safety summary) Unlike growth hormone therapies, AOD9604 does not meaningfully elevate IGF1 levels (human data), which may reduce the risk of unwanted growthrelated side effects